Moderna will start clinical trials against Omicron in the coming weeks




YEREVAN, 17 JANUARY, ARMENPRESS. The American Pharmaceutical company Moderna will start the clinical trials of vaccine against the Omicron strain in the coming weeks, ARMENPRESS reports, ''Interfax'' informs citing the announcement of the CEO of the Company Stéphane Bancel.

“The development of the vaccine comes to end. It must be tested in the coming weeks. We hope that in March we will have data that we can share with professionals in determining the next steps.” said Bancel during the online conference of the World Economic Forum (WEF).

Besides that, the CEO of Moderna mentioned that the aim of the company is to develop annual stimulator, which will be directed both against COVID-19, and flu.

“Thus, people will not have problems of meeting demands, when they do not wish to get vaccinated two or three doses in winter, they will have an opportunity to get vaccinated with one strong vaccine, which will defend from COVID, from flu.” he mentioned.

According to him in the best scenario such stimulant can be accessible until fall 2023, at least in a number of countries.

Emil Lazarian

“I should like to see any power of the world destroy this race, this small tribe of unimportant people, whose wars have all been fought and lost, whose structures have crumbled, literature is unread, music is unheard, and prayers are no more answered. Go ahead, destroy Armenia . See if you can do it. Send them into the desert without bread or water. Burn their homes and churches. Then see if they will not laugh, sing and pray again. For when two of them meet anywhere in the world, see if they will not create a New Armenia.” - WS